Clinical Trials Directory

Trials / Completed

CompletedNCT02915549

Early Progressive Feeding in Human-Milk Fed Extremely Preterm Infants: A Randomized Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
University of Alabama at Birmingham · Academic / Other
Sex
All
Age
24 Hours – 48 Hours
Healthy volunteers
Not accepted

Summary

To test the hypothesis that progressive feeding without minimal enteral feeding (MEF) compared to progressive feeding preceded by a 4-day course of MEF will result in an increased number of days alive on full enteral feeding in the first 28 days after birth in extremely preterm infants receiving human milk.

Detailed description

Qualifying participants will be randomly assigned to one of two study groups: 1) Early progressive feeding without MEF or 2) Progressive feedings preceded by 4 days of MEF. Regardless of study group assignment, donor human milk will be offered if not enough of the mother's expressed breastmilk during the intervention phase of the trial. Intervention group: Progressive feeding of 20-24 ml/kg/d on day 1 of feeding, followed by daily increments of 24-25 ml/kg/d as tolerated until full enteral feeding achieved. Control group: MEF with feeding volumes of 20-24 ml/kg/d for 4 days followed by progressive feeding (daily increments of 24-25 ml/kg/d) as tolerated until full enteral feeding achieved. Both groups will receive fast progressive feeding (\>/= 24 ml/kg/day) If parent agrees, stool "dirty" diapers will be collected 5 times (at birth, 1, 2, 3 and 4 weeks of life).

Conditions

Interventions

TypeNameDescription
OTHERProgressive Feeding without MEFThis group will receive feeding volumes of 20-24ml/kg/d of day 1 of feeding followed by the study intervention of daily volume increases in increments of 24-25ml/kg/d as tolerated until full enteral feeding is achieved.
OTHERProgressive Feeding with MEFThis group will receive minimal enteral feeds (MEF) with volumes of 20-24ml/kg/d for 4 days followed by daily increases in increments of 24-25ml/kg/d as tolerated until full enteral feeding is achieved.

Timeline

Start date
2016-09-01
Primary completion
2017-10-01
Completion
2022-11-01
First posted
2016-09-27
Last updated
2022-12-16

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02915549. Inclusion in this directory is not an endorsement.